We treated 26 hypothyroid women -11 with autoimmune thyroiditis and 15 who had been treated for thyroid cancer -with their usual dose of thyroxine (T % ) or with a regimen in which 50 µg of T % had been replaced by 12.5 µg of triiodothyronine (T $ ). Patients were first randomly assigned to one regimen for 5 wk and then to a second regimen for an additional 5 wk. The substitution of T $ for a portion of T % caused expected changes in concentrations of thyroid hormones and thyroid-stimulating hormone (TSH). After combined hormone treatment there were clear improvements in both cognition and mood, the latter changes being greater. The patients who had been treated for thyroid cancer showed more mental improvement than the women with autoimmune thyroiditis, perhaps because they were more dependent on exogenous hormone. Some mood improvements correlated positively with changes in TSH while others correlated negatively with changes in free T % .
Introduction
In a previous report (Bunevicius et al., 1999) our group described the results of treating 33 hypothyroid patients with thyroxine (T % ) alone or with a reduced amount of T % combined with a small amount of triiodothyronine (T $ ). The two treatment programmes exerted about equal metabolic effects and produced only expected biochemical effects, with one exception, combined hormone treatment increased the concentration of sex hormone-binding globulin (SH-BG) from low normal to high normal. Many improvements in psychological function occurred after combined treatment, and in the present report we have focused in detail on these changes. We have set aside metabolic and biochemical effects except as the latter correlate with psychological effects. To achieve these ends we have purified the sample, deleting from consideration the data that pertain to the 2 men in the larger sample and to the 4 women who had substantial test scores for depression. Another woman was found to have had a high TSH concentration (12.5 µU\ml) at baseline, probably due to inadequately treated autoimmune thyroiditis. Data pertaining to her were also deleted.
The remaining patients, who are the subject of the present report, are 26 women, 11 of whom had autoimmune thyroiditis (AT) and 15 of whom had been treated with thyroidectomy for thyroid cancer (TC). The scrutiny and comparison of these two groups is of interest because AT is a common disease (Tunbridge et al., 1977) and because TC is increasingly common, at least in parts of the world where large numbers of people have been accidentally exposed to radioactive iodine (Kazakov et al., 1992) . Thus, many patients, the majority of whom are women, require thyroid hormone replacement.
The thyroid gland secretes both T % and T $ . It is the only source of T % , secreting about 100 µg\d. It also secretes at least 6 µg\d of T $ , approx. 24 µg more coming from deiodination of T % by tissues, including brain (Pilo et al., 1990) . It is conventional to provide replacement treatment with T % alone, in the belief that each tissue will make sufficient quantities of T $ (the more potent hormone) for its own needs. Nevertheless, it has long been noted that after treatment with T % alone not all patients are entirely well . Moreover, not all tissues are equally able to perform deiodination (Visser et al., 1982) , and the deiodinase in the brain is different from the deiodinase in the periphery (Leonard and Kohrle, 1996) .
Methods

Patients
Patients were invited to participate if they fulfilled the following criteria : (i) attended the Institute of Endocrinology of the Kaunas Medical University in Kaunas, Lithuania, (ii) had AT or had been treated for TC with total thyroidectomy, (iii) were totally or near totally dependent on exogenous T % , (iv) had no other significant illness, and (v) gave written, informed consent. They were not selected because they had more than usual complaints. The initial characteristics of the two diagnostic groups are shown in Table 1 .
Study design
Each patient took her usual dose of T % up to and including the first day of the study. On this day each was assigned, according to a prearranged randomized schedule, to receive T % alone for 5 wk or to receive T % plus T $ for 5 wk. After 5 wk the second treatment was given. Each patient's regimens were based on her usual dose of T % . T % was given in usual tablet form except that 50 µg of T % was contained in a capsule. Other capsules of identical appearance contained 12.5 µg of T $ . If a patient, for example, had been treated with 150 µg\d of T % , she was instructed to take 100 µg of the usual T % tablets plus one capsule. Patients took medications once daily, half an hour before breakfast.
At the end of the first 5-wk period each patient was given another batch of tablets and capsules. Only the pharmacist knew which capsules had been dispensed. Patients, when asked at the end of each treatment period, said that they had taken their medications as instructed.
Evaluations
Patients were systematically studied on the last day of the two treatment periods. Having omitted breakfast but having taken their thyroid hormone about 2 h earlier, they reported to the clinic at 09 : 00 hours. Blood was drawn for measurement of biochemical variables. Assessments were made of cognitive function and psychological state, each patient having the same examiner for whatever variable was being measured. The examiners were ignorant of the patients' treatment assignments.
Biochemical measurements
Serum samples were frozen so that the samples from all patients could be analysed at the same time for a given variable. TSH was measured by immunoradiometric assay with kits obtained from Orion Diagnostica (Espoo, Finland) , with a sensitivity of 0.05 µU\ml. Serum-free T % , total T % and total T $ were measured with radioimmunoassay kits (Orion Diagnostica). Intra-assay variation was between 3 and 6 %.
Psychological measurements
Cognitive functioning was measured by use of three tests : the Digit Symbol test (Wechsler, 1981) , the Digit Span test of the Wechsler Adult Intelligence Scale (Wechsler, 1981) , and the Visual Scanning test (Weintraub and Mesulam, 1985) . In the Digit Symbol test a key is shown that pairs each of the digits 1-9 with a nonsense symbol. Below are rows of pairs of squares ; the upper square contains a number, the lower square is blank. Using the key, the subject is allowed 90 s to complete each pair of squares, entering the appropriate symbol. The raw score consists of the number of correct entries completed in 90 s or until completion of the third row, whichever occurs first. The score indicates psychomotor performance. Without using the key, the subject then attempts to recall which symbol matched each number. The number of pairs correctly recalled indicates incidental learning. Then the subject copies 70 symbols. The less time required for completion, the greater the subject's psychomotor speed.
In the first part of the Digit Span test the subject is required to repeat spoken numbers with increasing numbers of digits ; this indicates immediate auditory attention. The second part of the test requires the subject to repeat the numbers in reverse order, indicating mental flexibility.
The Visual Scanning test measures distractibility and visual inattentiveness. First the subject is shown a target symbol, and is then presented with a paper on which is displayed a matrix of symbols containing 60 copies of the target. The patient circles all the target symbols that she can find. The time needed to complete the test, omissions, and errors are scored.
Three mood scales were completed by each patient : the Beck Depression Inventory (BDI) (Beck et al., 1961) , the Spielberger State-Trait Anxiety Inventory (SSTAI) (Spielberger et al., 1983) , and the Profile of Mood States (POMS) (McNair et al., 1992) . The BDI is a self-rating scale consisting of 21 items. Scores of 10 or less indicate normal mood variation while scores of 11 or more reflect increasing degrees of depression. The SSTAI, also a selfrating scale, consists of 20 items. Scores below 50 are normal. The POMS measures affective states. The subject responds to 65 items, each pertaining to an aspect of subjective state, on a scale from 0 to 4. Scores for combinations of items are added, yielding values for six aspects of mood and a global score.
Eight visual analogue scales provided detailed ratings of mood. Each scale consists of a pair of contrasting Mental improvement after T % plus T $ replacement therapy phrases, such as ' sad as possible ' and ' happy as possible ' at either end of a 100 mm line. The patient marks the point on each line best corresponding to her state at that time.
Statistical analysis
Paired t tests were used to compare paired data from the two treatment periods. Non-paired t tests were used to compare values in subgroups of patients. Pearson productmoment correlation coefficient was used to examine relationships among selected measurements (Wilkinson et al., 1992) . Probability values were based on two-sided analyses of test results. All p values greater than 0.05 were regarded as non-significant. Absolute values are expressed as meanpstandard deviation. Table 1 shows that the patients in the two diagnostic groups were about the same age. The women with TC had not taken T % as long as had the women with AT but had been prescribed larger doses to suppress whatever residual thyroid tissue they might have had. Probably, as a consequence of these larger doses, their T % concentrations were greater and their TSH concentrations were smaller. Table 2 shows that the substitution of 12.5 µg of T $ for 50 µg of T % caused biochemical changes that were mostly expected. In both diagnostic groups the concentrations of free T % and of total T % were diminished while the concentration of total T $ was increased. The concentration of TSH was slightly diminished in the AT group while it was slightly increased in the TC group. Neither of these two effects was statistically significant, suggesting that the two treatments exerted about equal metabolic effects. It should be noted that for each of the TSH mean values (after combined hormone treatment) the standard deviation was large, indicating that for both diagnostic groups some patients experienced increases while others experienced decreases. Table 3 shows that in the women with AT the two hormone treatments exerted about equal effects on measures of cognition. In the women with TC, on the other hand, statistically significant improvement occurred in ' numbers of pairs correctly recalled ' (Visual Scanning test) and in ' time needed to perform ' (Visual Scanning test). Table 4 shows that in neither diagnostic group did the two treatments exert significantly different effects on either the BDI or the SSTAI.
Results
Clear difference did occur on the POMS. In the AT group, combined treatment tended to produce benefits on 5 of the 7 scales, though none of these tendencies was statistically significant. (Unlike the other subscales, the vigour-activity subscale indicates improvement when the score is increased.) In the TC group improvement tended to occur on 6 of the 7 POMS scales, and the effect was statistically significant on 4. It should be noted that the POMS is weighted towards mood items while the BDI contains many cognitive items. Table 5 shows results on the visual analogue scales. For each diagnostic group, on all 8 scales, there was at least a tendency for improvement after T % plus T $ compared to T % alone. The one exception occurred in the AT group, who showed a slight tendency to describe more agitation after combined treatment. The advantages for combined treatment were statistically significant in the AT group on 4 scales, in the TC group on 6 scales. Table 6 shows the statistically significant correlations between changes in mood and changes in the serum biochemical variables : TSH, free T % , total T % , and total T $ . As shown earlier in Table 2 , combined hormone treatment caused robust decreases in free T % and total T % and a robust increase in total T $ . Changes in TSH were slighta decrease in the AT group ; an increase in the TC group -and variances around the means were large. After combined hormone treatment, TSH changes were as follows : AT group, 5 decreases, 6 increases ; TC group, 5 decreases, 10 increases. It is important to note that while many improvements in mood occurred (Tables 4 and 5 (Table 6 ). Changes in TSH serum concentration correlated positively with 5 changes in mood : when TSH increased, mood improved ; when TSH decreased, mood worsened, however slightly. In addition, after combined hormone treatment, as free T % fell, mood improved and two negative correlations emerged. No correlations between mood and total T % or between mood and total T $ occurred.
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Side-effects tended to be less after T % plus T $ than after T % alone (data not shown). This was apparent on 6 of 7 visual analogue scales pertaining to mental and somatic symptoms (Bunevicius et al., 1999) .
Discussion
It appears that the amount of T $ , however small, normally secreted by the thyroid gland is necessary for the maintenance of normal brain function. Patients who more lacked T $ secretion, i.e. patients with thyroidectomy for cancer, profited more from combined treatment than did patients with residual thyroid function, i.e. patients with thyroiditis. The substitution of T $ in approximately physiological amounts (or slight excess) for a portion of exogenous T % benefited both cognition and mood, two functions adversely affected by hypothyroidism (Whybrow et al., 1969) . Both performance tests and subjective ratings supported these observations. The improvement in mood was greater than the improvement in cognition.
Two other groups have studied the role of T $ in thyroid hormone replacement. Smith et al. (1970) used very large doses of both T % and T $ . Their patients preferred T % alone, presumably because it caused less toxicity. Cooke et al. (1992) performed an open trial that involved nine depressed patients receiving T % replacement but responding poorly to their antidepressant drugs. When the authors added T $ (15-50 µg) to the daily regimen, a marked decrease in depression occurred in 7 patients.
More recent evidence from both the clinic and the laboratory suggests that T $ can play a useful role in replacement therapy. Van Wassenaer et al. (1998) gave T % to premature human infants. Hypothyroxinaemia was corrected but the pattern of thyroid hormones caused the authors to suggest that T $ might play a useful role in treatment. Escobar-Morreale et al. (1996) thyroidectomized rats, gave them various doses of T % and studied tissue concentrations of T % and T $ . They did not find a dose of T % that would fully restore tissue concentrations of T $ . Cerebral cortex and cerebellum were exceptions to this finding. These exceptions, pertaining to parts of the brain, appear to contradict the thrust of the present report. However, Campos-Barros et al. (1996) have identified differences between rat brain and human brain in T $ production.
The results regarding magnitude of change in TSH concentration by themselves could be taken as reflecting the importance for mood improvement of simply changing the existing dynamics of the hypothalamicpituitary-thyroid axis. The variability in TSH response to combined hormone treatment, especially the frequent increase in TSH concentration, though not expected, is not without precedent. Ridgway et al. (1979) reported that T $ treatment of hypothyroid patients increased TSH secretion evident in the TRH stimulation test.
There are several ways in which T $ administration might improve mental function. Increased serum concentrations of T $ will cause more T $ to be presented to the brain, and in brain T $ , among other functions, may act as a neurotransmitter (Mason et al., 1993) . Furthermore, T $ alters the dynamics of several classical neurotransmitters in the brain in such a way as might enhance mood (Mason et al., 1987a-c) . Gur et al. (1999) have recently shown that T $ exerts a positive effect on serotonin in the rat frontal cortex.
The administration of T $ in patients whose thyroid gland cannot secrete it will produce a pattern of thyroid hormones in serum that almost reaches normal. This may be important because the production of T $ from T % by the 5hDII enzyme is modulated in brain by serum thyroid hormones (Leonard and Kohrle, 1996) . 5hDII activity and local T $ production are rapidly inactivated by elevated T % and reverse T $ levels, whereas T $ itself has only a minor influence. T % also activates its own conversion to reverse T $ , which, as noted, in turn inhibits T $ production (Kohrle, 1999) .
In the present study a correlate with improved mood was decreased concentration of T % , its free, active moiety. Whatever the change in TSH, free T % decreased in 22 of 26 patients. However, caution must guide the interpretation of the correlations presented in Table 6 . Eighteen mood variables were tested against four biochemical variables for two diagnostic groups. Only seven statistically significant correlations were found in this matrix of 144 tests. It may not be chance, however, that caused all seven significant correlations to pertain to only 2 of the 4 biochemical variables.
If reducing brain concentration of T % , whatever its downstream consequences might be, were the only factor in causing mood improvement after T $ administration, then induced increases of T % might be expected to have untoward mood effects. Here a study of patients with depression may be germane. Prange et al. (1970) prefaced standard imipramine treatment of depressed women with an intramuscular dose of bovine TSH or placebo. The women who received TSH experienced a doubling in protein-bound iodine, a measure mainly of total T % , in 24 h and in the following days a much more rapid Mental improvement after T % plus T $ replacement therapy antidepressant response. Of course, T $ concentrations, which were not then measurable, may also have increased, because it is now known that when TSH secretion is suddenly evoked by intravenous administration of thyrotropin-releasing hormone, T $ , as well as T % concentration, is increased even more promptly (Hollander et al., 1972) . However, if a single stimulus evokes the sudden secretion of both T $ and T % , the latter will persist in serum for days, not hours, due to differences in half-lives.
Is it useful, in patients with depression, to lower T % , except by T $ administration ? Joffe and Levitt (1993) provided a full consideration of this issue. Lithium is an example of an antithyroid drug with psychotropic effects, and lithium, like T $ , has been shown to be an effective augmentation agent in drug-resistant depression (Aronson et al., 1996 ; Dufresne, 1996) . Although it is an antithyroid agent, lithium, in fact, may increase T $ activity in the brain. Baumgartner et al. (1995) have made this observation and have related T $ activation to lithium's efficacy in preventing relapse in affective disorders. Moreover, Bolaris et al. (1995) , performing both in vivo and in vitro studies in rats, demonstrated that lithium causes an increase in nuclear T $ binding in brain tissue. In any case, it should be recalled that the mental symptoms of hypothyroidism, not those of hyperthyroidism, resemble those of depression (Nemeroff and Evans, 1989) .
Whatever the solution to the foregoing puzzle, one might ask why the thyroid gland bothers, as it were, to secrete any T $ , however little it may be. There are several situations in which a shift toward T $ secretion appears adaptive : incipient thyroid gland failure (Ingbar, 1985) ; shortage of dietary iodine (Delange et al., 1972) , and forced overeating (Utiger, 1982) . Of course, the shifts in these conditions may reflect increased deiodination of T % rather than, or as well as, increased glandular secretion of T $ . Apart from whatever role T $ may play in stressful situations, present data suggest it may also play a role in usual situations. Glandular secretion of T $ may provide a base to which other tissues make additions by deiodination of T % , achieving from this combination of sources their needed concentration of T $ . When such base is deficient, the consequences may be more readily discerned in the functions of brain than in the functions of other tissues.
